{
    "title": "New cancer immunotherapy fails in first Roche trial",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10666863/Roche-late-stage-trial-immunotherapy-lung-cancer-treatment-fails.html",
    "date": "2022-03-30",
    "keywords": [
        "cancer",
        "drug",
        "roche",
        "lung",
        "tiragolumab",
        "tecentriq",
        "john",
        "trial",
        "cell",
        "immunotherapy",
        "progression",
        "stage",
        "chemotherapy",
        "disease",
        "option",
        "deal",
        "burger",
        "form",
        "maker",
        "wednesday",
        "boding",
        "ill",
        "range",
        "skyscraper",
        "testing",
        "class",
        "antitigit",
        "unit",
        "genentech",
        "programme",
        "statement",
        "company",
        "rate",
        "death",
        "group",
        "bank",
        "zkb",
        "trading",
        "health",
        "care",
        "index",
        "outcome",
        "smallcell",
        "garraway",
        "officer",
        "head",
        "product",
        "development",
        "firstgeneration",
        "cos",
        "keytruda",
        "analyst",
        "stefan",
        "schneider",
        "failure",
        "condition",
        "result",
        "probability",
        "success",
        "year",
        "work",
        "combo",
        "potential",
        "receptor",
        "system",
        "attack",
        "mechanism",
        "tigit",
        "treatment",
        "research",
        "activity",
        "view",
        "combination",
        "june",
        "licensing",
        "candidate",
        "eos448",
        "agen1777",
        "partnership",
        "gilead",
        "november",
        "reporting",
        "revill",
        "paul",
        "carrel",
        "stonestreet"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}